Recent literature in inflammatory myopathies suggests that both immune (cell-mediated and humoral) and nonimmune [endoplasmic reticulum (ER) stress and autophagy] mechanisms play a role in muscle fiber damage and dysfunction. This review describes these findings and discusses their relevance to disease pathogenesis and therapy.
Introduction
Muscle weakness and inflammation are characteristic features of idiopathic inflammatory myopathies (IIMs), but the molecular pathways that initiate and perpetuate the muscle damage are currently unclear. It is generally thought that IIMs are autoimmune in origin because of the presence of autoantibodies, frequent association with other autoimmune diseases and favorable response in some patients to immunosuppressive therapies. Current literature supports two major immune mediators of muscle damage in myositis: one mediated through T lymphocytes (cytotoxic T cells) directed against muscle fibers, predominating in polymyositis and inclusion body myositis (IBM), and the other mediated through humoral factors (antibodies and complement) directed against vessels, predominating in patients with dermatomyositis. The relative contribution of immune pathways to disease pathogenesis is undefined. On the contrary, several studies have shown evidence that nonimmune processes may also have a role in the pathogenesis of myositis. For example, the degree of inflammation in skeletal muscle does not consistently correlate with the severity of the structural changes observed in the muscle fibers or with the severity of the clinical disease [1,2]; striking structural changes in the muscle fibers occur even in the absence of any inflammatory cells in muscle [3, 4] ; some myositis patients do not respond even to potent anti-inflammatory therapy [5, 6] ; glucocorticoid treatment may eliminate muscle inflammation without substantial improvement in the clinical disease [7] ; and the clinical disease may still progress when identifiable inflammation has subsided [8] . Collectively, these data suggest a potential role for nonimmune mechanisms in the pathogenesis of myositis, and the exact nature and roles of these pathways in myositis pathogenesis are becoming evident in the recent literature. This review will discuss recent advances in nonimmune mechanism [e.g., the endoplasmic reticulum (ER) stress, autophagy and nuclear factor (NF)-kB activation] of muscle fiber damage and dysfunction in myositis.
Figure 1 Endoplasmic reticulum and sarcoplasmic reticulum interactions within mammalian cells
Illustration showing physical contact between ER (or SR) with other organelles and plasma membrane (upper panel). Individual interactions and cellular responses are numbered and depicted in lower panels; panel 1 shows the requirement of STIM1 oligomers as a Ca 2þ sensor and the Orai channel for SR reload with Ca 2þ from the extracellular environment. Panel 2 shows that UPR relies on the release of BiP from the stress sensors when unfolded proteins accumulate in the organelle. Without BiP, IRE1 and PERK form homodymers and their cytoplasmic portions are cleaved and free to interact with XBP1 and eIF2a to increase the transcription of housekeeping genes and translation attenuation, respectively. The BiP-free ATF6 is targeted to the Golgi in which its cytoplasmic portion is also cleaved and released to migrate to the nucleus for transcriptional activation. Panel 3 shows that Ca 2þ exchange between SR (and ER) and mitochondria is mediated by RyR, VDAC and MCU for Ca 2þ influx from SR to mitochondria. For influx from mitochondria to SR, the players are an undefined channel (?, in figure), VDAC and SERCA. SERCA also mediates Ca 2þ influx from cytoplasm to SR.
Endoplasmic reticulum stress response pathway
The ER performs important tasks such as Ca 2þ release, posttranslational maturation, protein folding/quality control, lipids' biosynthesis andantigen presentation (Table1). The ER has inbuilt mechanisms to control malfunction of above processes through a variety of homeostatic responses. However, when this housekeeping response is not sufficient to bring the cell to normal function, intrinsic cell death pathways are automatically triggered.
As illustrated in Fig. 1 , the ER is intimately connected to other cellular components and likely to affect many cellular functions during homeostasis, cell stress and cell death ( Fig. 1 and Table 1 ). It is now known that the ER and sarcoplasmic reticulum can rapidly be reloaded with Ca 2þ from the extracellular environment via the Ca 2þ sensors stromal interaction molecules (STIM) and the associated Ca 2þ channel Orai in the plasma membrane [9 ] (Fig. 1, panel 1 ). Importantly, abnormalities in this pathway have been recently associated with skeletal myopathy and death [10 ] .
In mammalian cells, the ER senses and responds to stress through three cellular pathways: inositol-requiring 1 (IRE1), PKR-like ER kinase (PERK) and activating transcription factor 6 (ATF6) ( Fig. 1, panel 2 ). All the three pathways under normal conditions are kept inactive by glucose-regulated protein-78 (GRP78), also referred to as the ER luminal immunoglobulin-binding protein (BiP). However, when unfolded proteins accumulate within the ER, BiP is released from the three sensors and helps folding of accumulated proteins. This process is generally known as unfolded protein response (UPR), and the release of BiP from IRE1 and PERK leads to homodimerization and release of their cytoplasmic portions [11 ] . IRE1 then activates the transcription factor X-box-binding protein 1 (XBP1) that induces the production of many ER stress-inducible genes, including members of the Hsp40 family, ER chaperones and XBP1 itself and degradation of other subsets of mRNA [12] (Fig. 1, panel 2 ). On the contrary, the immediate consequence of PERK activation is translation attenuation through the phosphorylation of the a-subunit of heterotrimeric eukaryotic initiator factor 2-alpha (eIF2a) [13] . The dissociation of BiP from ATF6 permits its translocation to the Golgi (Fig. 1 , panel 2), in which its cytoplasmic portion is cleaved by site-1 and site-2 proteases to generate a cytosolic fragment. These fragments then migrate to the nucleus and induce the expression of genes with ER response elements (ERSE) in their promoters [e.g., GRP78, GRP94, calre-ticulum6, C/EBP homologous protein (CHOP), XBP1, Orp 150 (Grp170) and protein disulphide isomerase P5] that in turn help to relieve ER stress.
Concomitant to the above biochemical pathways triggered by the ER, unfolded proteins are targeted to retrotransport to cytoplasm, probably through Sec61, Mechanisms of muscle damage in myositis Henriques-Pons and Nagaraju 583 . Panel 4 shows some components of the autophagic pathway are depicted, starting with the Atg1 kinase homologue, ULK1 in mammals, which is silenced by Bcl-2 located on the ER and by m-TOR (panel 4). Then, the PI3K complex is formed, composed of Beclin-1, P150, phosphorylated Vps34 (a class III PI3K) and UVRAG in mammals. The next step represented is the elongation of the phagophore through the addition of LC3-PE (phosphatidylethanolamine) for lysosomal degradation of sequestered components in the closed autophagosome. ATF6, activating transcription factor 6; BiP, ER luminal-binding protein; eIF2a, eukaryotic initiator factor 2-alpha; ER, endoplasmic reticulum; ERAD, ER-associated degradation; IRE1, inositol-requiring 1; MCU, mitochondrial Ca 2þ uniport; m-TOR, mammalian target of rapamycin; PERK, PKR-like endoplasmic reticulum kinase; PI3K, phosphoinositide 3 kinase; PM, plasma membrane; RyR, ryanodine receptor; SERCA, sarcoplasmic reticulum/endoplasmic reticulum Ca 2þ -ATPase pumps; SR, sarcoplasmic reticulum; STIM, stromal interaction molecules; ULK1, unc-51-like kinase; UPR, unfolded protein response; UVRAG, ultraviolet irradiation resistance-associated gene; VDAC, voltage-dependent anion channel; XBP1, X-boxbinding protein 1. ubiquitinylation and degradation by the 26S proteasome through ER-associated degradation (ERAD) process ( Fig. 1 ). This is a highly complex and ill-defined process that starts, at least for some glycoproteins, with the action of the ER degradation-enhancing a-mannosidase-like proteins (EDEM) [14] .
The role of ER and its associated proteins is becoming clear in several inflammatory muscle diseases including IBM. A recent study showed that the expression of ER-bound RING finger protein 5, RNF5 (aka RMA1), an ER-anchored RING finger E3 ligase, is involved in the recognition and processing of malfolded proteins. This study also demonstrated that expression of RNF5 is increased and localized to cytoplasmic aggregates in sporadic IBM (sIBM). Moreover, prolonged expression of RNF results in the formation of muscle fibers containing congophilic material, blue-rimmed vacuoles and inclusion bodies, indicating a role for RNF5 in the ER stressassociated myopathies and in muscle physiology [15 ] .
Role of sarcoplasmic and endoplasmic reticulum in disease
The ER and sarcoplasmic reticulum are distinct organelles with different cellular functions. The sarcoplasmic reticulum is found in muscle cells and is a specialized form of the ER, with a particular distribution of domains and proteins along the contractile unit of muscle fibers that is dedicated to the storage and controlled release of Ca 2þ . On the contrary, the ER is a net-like labyrinth of tubules that is formed from the nuclear envelope by flattened stacks and budding vesicles that performs more complex cellular processes (Table 1) . To understand the role of ER stress in disease conditions, it is important to first understand the function of ER and sarcoplasmic reticulum in normal cells. The longitudinal region of sarcoplasmic reticulum is specialized in Ca 2þ uptake by sarcoplasmic reticulum/ER Ca 2þ -ATPase pumps (SERCA), and the junctional domain of sarcoplasmic reticulum is enriched in the Ca 2þ -releasing channel, ryanodine receptor type 1 (RyR1) and other junctional proteins (Fig. 1, panel 3) . Ca 2þ is stored within the organelle associated with calsequestrin 1, the main calcium buffer of skeletal muscle cells, which also controls the morphological distribution of sarcoplasmic reticulum junctional domains, terminal cisternae volume, density and function of RyR through phosphorylation events. Calsequestrin 1 acts as a luminal Ca 2þ sensor for RyR via its interactions with triadin and junctin. The close relationship between altered expression and dysfunction of calsequestrin in several skeletal and cardiac disorders highlights its role in maintaining Ca 2þ homeostasis and regulation of muscle contraction. Although the sarcoplasmic reticulum stress response is not well studied, it appears that volume alteration triggered by osmotic shock in skeletal fibers induces localized and sustained sarcoplasmic reticulum Ca 2þ release, contributing to skeletal muscle plasticity and/or disorder (Table 1 ) [16] .
Recent studies using mice deficient in hexose-6-phosphate dehydrogenase (H6PD), an enzyme that generates NADPH via pentose phosphate pathway inside the ER, further illustrate the role of ER stress in skeletal muscle function [17 ] . H6PD-deficient mice showed severe skeletal myopathy and exhibited fasting hypoglycemia, increased insulin sensitivity and increased basal and insulin-stimulated glucose uptake in type II (fast) muscle fibers, suggesting mild insensitivity to glucocorticoids. These studies also showed that affected muscles have normal sarcomeric structures but have large intrafibrillar membranous vacuoles and abnormal triads, suggesting an altered redox state of sarcoplasmic reticulum leading to activation of UPR and myopathy [17 ] .
Although the phenotypic consequences of abnormal intracellular accumulation of proteins are not well studied, it was recently showed that skeletal muscle with accumulated b-amyloid generates less peak force and exhibited transient Ca 2þ peaks with lower amplitude. Further, the addition of amyloid-b peptide (Ab1-42) to sarcoplasmic reticulum vesicles resulted in RyRmediated Ca 2þ release, indicating that altered protein metabolism in IBM changes RyR-mediated Ca 2þ release and muscle contractility [18] .
Mitochondria is one of the organelles that make intimate contact with ER, in fact about 12% of the outer mitochondrial membrane physically contacts the ER in specialized areas called mitochondria-associated ER membrane (MAM) (Fig. 1, panel 3) [19] . This interaction is considered to play major roles in the nonvesicular transport of phospholipids, control of apoptosis and Ca 2þ exchange between the two organelles [20] . The MAM is particularly enriched in functionally diverse enzymes including enzymes involved in protein oxidation. The oxidative folding of proteins in the ER is critical for cell function, and the abnormal protein oxidation contributes to several diseases [21] . There are evidences that mitochondrial oxidative stress plays a major role in the pathogenesis of neurodegenerative diseases such as Alzheimer's or Parkinson's disease, and probably, the interplay between ER and mitochondrial dysfunctions play a role in protein oxidation in IBM and polymyositis [22] .
Endoplasmic reticulum stress, autophagy and cell death
Apoptosis and autophagy cell death have different morphological characteristics and pathways. Although the role of autophagy in different forms of myositis is not clear, in normal mammalian cells, it starts with the activation of the phagophore, elongation of this membranous structure and finally fusion with lysosome ( Fig. 1,  panel 4 ). Autophagy is a multistep process that sequesters and recycles cytosolic components constitutively, during nutrients deprivation or stress, but can lead to cell death when uncontrolled [23] . Recently, some studies [24, 25] showed that characteristic apoptotic changes are absent in skeletal muscle of myositis patients, probably due to the expression of antiapoptotic molecules in the muscle. However, skeletal muscle death and damage occurs in muscle fibers of myositis patients, despite the overexpression of various antiapoptotic molecules, indicating that other forms of cell death, such as autophagy, are involved. Indeed, recent literature provides some evidence that ER stress response in other cells is associated not only with classic apoptotic cell death but also with autophagic cell death. On the contrary, components of apoptotic pathways may modulate autophagy through cross-talk interactions, including transcriptional activation of proapoptotic Bcl-2 family members or death receptors and activation of initiator caspases at the ER. This is illustrated by the downregulation of autophagic cell death through the binding of Bcl-2 to Beclin 1, avoiding its association with phosphoinositide 3 kinase (PI3K) complex (Fig. 1,  panel 4) . Interestingly, the role of Bcl-2 in antagonizing Beclin 1-dependent autophagy is restricted to Bcl-2 located at the ER [26] . It is becoming increasingly clear that ER stress response and autophagy are linked, for example, a recent study [27] provided evidence that endogenous ER degradation-enhancing a mannosidaselike protein 1 (EDEM1) in nonstressed cells reaches the cytosol and is degraded by basal autophagy. Although caspases activation is not clearly linked to myositis, it has been well demonstrated that caspase-12 is involved in ER stress-induced apoptosis in murine cells, but its role in humans is unclear. It appears that the counterpart of murine caspase-12 in human is the caspase-4.
Autophagy in myopathies
The role of autophagy in diseases is relatively unexplained. A recent study compared clinical and histological features of muscle biopsy of polymyositis with mitochondrial disease (PM-Mito), steroid-responsive polymyositis and IBM. It was observed that selective weakness in the quadriceps or finger flexors was common in PM-Mito and IBM, and weakness progressed slower in PM-Mito than in IBM. This study [28] showed that autophagy markers LC3 and a-B-crystallin were found in PM-Mito and IBM but not in polymyositis biopsies. Another study indicated that Atg8/LC3 colocalizes with amyloid precursor protein (APP) in human muscle cells, and APP/ b-amyloid-containing autophagosomes are often observed at increased frequency in muscle fibers of sIBM muscle biopsies but not in nonmyopathic muscle or nonvacuolated myopathic controls. Collectively, these studies suggest that APP/b-amyloid is targeted for lysosomal degradation via autophagy in sIBM.
Loss of skeletal muscle mass occurs during denervationinduced disuse atrophy. Recent studies showed that degradation pathways such as autophagy are highly activated as indicated by the increased expression of Beclin 1 and translocation of LC3-II (LC3 associated with phosphatidylethanolamine) to mitochondrial membranes. These results suggest that autophagy signaling is upregulated in response to denervation and may preferentially target mitochondria for degradation in skeletal muscle [29] . Recently, it was also demonstrated that deficiency of VMA21, a component of V-ATPase proton pump complex, leads to mammalian target of rapamycin (mTOR)-dependent autophagy and causes vacuolation and atrophy of skeletal muscle in cell X-linked myopathy with excessive autophagy (XMEA) [30 ] . These findings may be relevant for the perifascicular atrophic phenotype seen in dermatomyositis muscle biopsies.
Muscle inflammation and damage is also seen in druginduced myopathies as well as genetic muscle diseases such as dysferlin deficiency. A recent study demonstrates that the wild-type dysferlin, but not the mutant protein, is degraded by ERAD. On the contrary, mutant dysferlin spontaneously aggregated in the ER and induced both ER stress and autophagy [31] . Moreover, it appears that accumulation of cell surface proteins such as major histocompatibility complex (MHC) class I in myositis muscle fibers may also lead to both ER stress and autophagy [32] . Using the model of chloroquine-induced myopathy, it was showed that as early as 3 weeks after drug treatment, autophagic marker LC3-II and amyloid-b increased in muscle fibers, followed by an increase in UPR markers such a GRP78 and an increase in SERCA by 5 weeks. This study [33] suggests that the rimmed vacuoles observed at 7 weeks after drug treatment are due to autophagy, and this process may have a role in diseases related to amyloid-b accumulation in IBM.
Muscle inflammation and nuclear factor-kB activation in myositis
Available literature strongly suggests that there is an active interaction between different cell types in the muscle microenvironment in myositis [34] . This interaction between immune and muscle cells results in either stimulation or inhibition of immune cells depending on the cell type. MHC class I is highly expressed in myositis muscle fibers, and the receptors that interact with MHC class I in myositis are undefined. A recent study [35] shows that leukocyte immunoglobulin-like receptor 1 (CD85j), but not CD158 [killer cell immunoglobulin-like receptors (KIRs)], is highly expressed in inflammatory cells in muscle, suggesting active interaction between skeletal muscle and immune cells (e.g., dendritic cells). Also, human skeletal muscle cells not only express common cell surface molecules such as MHC class I and intercellular adhesion molecule 1 (ICAM-1) but also certain immunoregulatory molecules such as B7 homolog 3 (B7-H3), which may protect from T cell-mediated damage to the skeletal muscle [36] .
The precise role of inflammation in muscle fiber damage and dysfunction in myositis is unclear. Although macrophages are the predominant cell type in polymyositis and dermatomyositis and express inducible nitric oxide synthase (iNOS) and transforming growth factor-beta (TGFb), for example, the relative contribution of these cells and how the differential expression of certain cytokines lead to histological and phenotypic differences in these diseases remain to be studied [37] . A recent study indicates that chronic inflammation (LPS exposure) in a transgenic mouse model increases b-amyloid generation and tau phosphorylation in skeletal muscle through tau kinase and glycogen synthase kinase-3-beta (GSK-3b). They showed that suppression of GSK-3b activity significantly reduced tau phosphorylation, and there was partial recovery of motor impairment in the mouse model [38] . Another independent study also supports the link between expression of APP and inflammation in the muscle. This study [39] showed colocalization of interleukin (IL)-1b with b-amyloid depositions within myofibers, suggesting that proinflammatory mediators specifically induce b-amyloid-associated skeletal muscle degeneration. Another study [40] also suggested that decreased activity of sirtuin 1 (SIRT1), a member of NAD (þ)-dependent histone/protein deacetylases, increases NF-kB activation and amyloid-b accumulation in sIBM muscle. All these studies clearly suggest that accumulation of b-amyoid is controlled by inflammatory pathways, and targeting specific inflammatory pathways is likely to be beneficial in IBM.
NF-kB is the master regulator of inflammation that is activated not only in immune cells but also in skeletal muscle cells under inflammatory conditions. NF-kB can be activated quickly by a wide variety of stimuli, including inflammatory cytokines [e.g., tumor necrosis factoralpha (TNFa) and IL-1], T-cell activation signals and cell stress inducers. Recent investigations indicated that overexpression of MHC class I on muscle fibers indeed results in activation of the NF-kB and ER stress response pathway in human inflammatory myopathies and in the mouse model of myositis [32, 41, 42] (Table 1) . Further, there is strong evidence that downstream NF-kB target genes [e.g., MHC class I, ICAM and monocyte chemotactic protein-1 (MCP-1)] are highly upregulated in myositis muscle. It is likely that both classical (proinflammatory cytokine induced) and nonclassical (ER stress response induced) pathways activate NF-kB in myositis (Fig. 2) [41] [42] [43] [44] . Therefore, NF-kB may be a common and potential therapeutic target in all forms of myositis, and use of specific NF-kB pathway inhibitors is likely to be beneficial in these disease conditions.
Conclusion
Recent studies provide strong evidence that both immune (cell mediated in polymyositis and IBM and humoral in dermatomyositis) as well as nonimmune (ER stress response and autophagy) mechanisms play a role in muscle fiber damage and dysfunction in myositis. It appears that NF-kB bridges the link between these two pathways of muscle dysfunction in all forms of myositis. These data suggest that specific drug(s), which target both immune and nonimmune pathways, would serve as effective therapeutic agents for these disease conditions. 
